Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

9.06
-0.1950-2.11%
Volume:632.58K
Turnover:5.80M
Market Cap:1.65B
PE:-88.77
High:9.34
Open:9.34
Low:9.04
Close:9.25
52wk High:11.33
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.16
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-169.60
PE(LYR):2,823.51

Loading ...

Xeris Announces Updates to Its Board of Directors

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Marla Persky to Transition to Lead Independent Director

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Appoints John Shannon as Chair of the Board

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Gets Notice of Allowance From US Patent and Trademark Office for New KEVEYIS Patent

MT Newswires Live
·
Jun 12

Xeris Biopharma gets USPTO notice of allowance for Keveyis patent extending protection to 2039

Reuters
·
Jun 12

Analysts Are Bullish on Top Healthcare Stocks: Omnicell (OMCL), Xeris Pharmaceuticals (XERS)

TIPRANKS
·
Jun 11

Xeris Biopharma announces private exchange of convertible notes

TIPRANKS
·
Jun 11

BRIEF-Xeris Biopharma Announces Private Exchange Of Convertible Notes

Reuters
·
Jun 11

Xeris Biopharma retires USD 23 million of 8% convertible notes in cash-and-stock exchange

Reuters
·
Jun 11

Xeris Biopharma Announces Private Exchange of Convertible Notes

THOMSON REUTERS
·
Jun 11

Xeris Biopharma - to Retire $23 Mln Principal of Notes for $23 Mln Cash and Shares

THOMSON REUTERS
·
Jun 11

Savara COO Robert Lutz to take CFO role as Lowrance steps down for health reasons

Reuters
·
Jun 09

Xeris Biopharma director Marla Persky sells 15,500 shares worth $91,433.95

Reuters
·
Jun 06

Xeris Biopharma director Barbara-Jean Anne Bormann-Kennedy sells 16,000 shares for $97,507.2

Reuters
·
Jun 06

Xeris Biopharma director John Johnson sells 15,000 shares worth $91,422

Reuters
·
Jun 06

Xeris Biopharma Chief Legal Officer Beth Hecht sells 16,667 shares for $100,980.82

Reuters
·
Jun 03

Xeris Pharmaceuticals (XERS) Receives a Buy from Barclays

TIPRANKS
·
May 14

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Profit Turnaround And Guidance Hike

Simply Wall St.
·
May 11

Oppenheimer Sticks to Its Buy Rating for Xeris Pharmaceuticals (XERS)

TIPRANKS
·
May 08

Stock Track | Xeris Pharmaceuticals Soars 5.02% in Pre-market on Strong Q1 Results and Raised Guidance

Stock Track
·
May 07